Literature DB >> 21256753

Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome.

Girish Baburao Kulkarni1, A Mahadevan, A B Taly, T C Yasha, K Sangeetha Seshagiri, A Nalini, P Satishchandra, M Veerendrakumar, S K Shankar.   

Abstract

Patients with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome caused by underlying plasma cell dyscrasias, although rare, may present with peripheral neuropathy. In this retrospective study we describe the clinical, electrophysiological and pathological profile of 29 patients (27 males and two females, with a mean age of 45.9±7.9 years) seen between 1983 to 2009 who satisfied the Dispenzieri criteria. Polyneuropathy with weakness and paresthesias of the limbs evolving over 8.3±9.1 months, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes were seen in all patients. Other features included pedal edema (25 patients), papilledema (24), weight loss (23), clubbing (20) and Castleman disease (three patients). We report the pathological features seen in nerve biopsies, osteosclerotic lesions, skin biopsies, lymph node biopsies and bone marrow aspirates. We report the method of a diagnosis confirmation and compare the clinicopathological features of our patients with other published series. Our findings highlight the importance of a meticulous systemic examination and systematic laboratory investigations in the diagnosis of POEMS syndrome.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21256753     DOI: 10.1016/j.jocn.2010.07.124

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

Review 1.  Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

Authors:  Satoshi Kuwabara; Angela Dispenzieri; Kimiyoshi Arimura; Sonoko Misawa; Chiaki Nakaseko
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

2.  POEMS Syndrome: Clinical and Laboratory Approach Towards Diagnosis.

Authors:  Mala Mahto; Tarun Kumar; Mukunda Kumar; Gunjan Kumar; Sushil Kumar; Akash Bansal; Ayan Banerjee
Journal:  Indian J Clin Biochem       Date:  2021-01-03

Review 3.  POEMS Syndrome: an Enigma.

Authors:  Rahma Warsame; Uday Yanamandra; Prashant Kapoor
Journal:  Curr Hematol Malig Rep       Date:  2017-04       Impact factor: 4.213

4.  An unusual cause of type 2 respiratory failure.

Authors:  Srinivas Rajagopala; Balamurugan Nathan; Vivekanandan Pillai
Journal:  Indian J Crit Care Med       Date:  2015-02

5.  Nerve pathologic features differentiate POEMS syndrome from CIDP.

Authors:  Ezequiel A Piccione; Janean Engelstad; Peter J Dyck; Michelle L Mauermann; Angela Dispenzieri; P James B Dyck
Journal:  Acta Neuropathol Commun       Date:  2016-10-31       Impact factor: 7.801

6.  Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study.

Authors:  Yong Wang; Li-Bo Huang; Yi-Hua Shi; Huan Fu; Zhen Xu; Guo-Qing Zheng; Yan Wang
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

7.  Oocyte cryopreservation in the setting of a vascular endothelial growth factor (VEGF)-producing paraneoplastic syndrome: a case report and review of literature.

Authors:  Emily Spurlin; Paula Brady
Journal:  Fertil Res Pract       Date:  2020-10-28

Review 8.  Not the final diagnosis: from Addison's disease to POEMS syndrome: a case report and literature review.

Authors:  Xiaoxi Xie; Rao Li; Yongxia Lu; Xuan Li; Pu Kuang; Chunhui Wang; Nanwei Tong; Qingguo Lü
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

9.  POEMS syndrome presentation with progressive weakness in upper and lower limbs: A case report.

Authors:  Chuang-Jie Cao; Cheng-Yun Dou; Ke-Hua Zhou; Jin-Bo Liu; Hong Lai
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.